> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Expedited Programs for Regenerative Medicine Therapies
- URL: https://www.fdaweb.com/guide-on-expedited-programs-for-regenerative-medicine-therapies/
- Published: 2019-02-19T12:00:00.000Z
- Updated: 2026-09-15T01:05:47.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143407

*Federal Register* notice: FDA has made available a final guidance entitled “Expedited Programs for Regenerative Medicine Therapies for Serious Conditions.” The document describes the expedited programs available to sponsors developing regenerative medicine therapy for serious or life-threatening diseases or conditions. It also describes considerations in the clinical development of regenerative medicine therapies and opportunities for sponsors to interact with CBER review staff. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-02-19/pdf/2019-02691.pdf?ref=fdaweb.com).